Details for 2018821590
Up to date per 03.04.2026
Actions
Details for 2018821590
Deleted
European Patent
29.04.2020 A
08.06.2022 B1
20.06.2017
US
201762522214 P
23.06.2017
US
201762524237 P
16.02.2018
US
201862710316 P
02.03.2018
US
201862637434 P
26.03.2018
US
201862647926 P
C07D 213/80 20060101AFI20200929BHEP
Owner
Imbria Pharmaceuticals, Inc.12770 High Bluff Drive, Suite 270 San Diego, CA 92130US
Representative
No representatives present
Inventor
LEVIN, Andrew38 Eldredge Street Newton, MA 02458US